P1201: ZANUBRUTINIB PLUS RCHOP(ZR-CHOP) REGIMEN ACHIEVES HIGH COMPLETE RESPONSE RATE IN THE TREATMENT OF NEWLY-DIAGNOSED DOUBLE-EXPRESSION DIFFUSE LARGE B CELL LYMPHOMA

• Q. He,
• L. Xie,
• R. Zhao,
• J. Ma,
• C. Liu,
• C. Chen,
• H. Wang,
• K. Lu,
• J. Li,
• C. Zhao,
• N. Shan,
• L. Xing,
• Z. Li

Affiliations

Q. He

1 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences

L. Xie

1 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences

R. Zhao

1 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences

J. Ma

1 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences

C. Liu

1 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences

C. Chen

2 Qilu Hospital of Shandong University

H. Wang

1 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences

K. Lu

1 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences

J. Li

2 Qilu Hospital of Shandong University

C. Zhao

2 Qilu Hospital of Shandong University

N. Shan

3 Shandong Provincial Hospital, jinan, China

L. Xing

1 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences

Z. Li

1 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences